Zimbuck – Your Market. Your Community.
Insmed Shares Jump 21% as Sanofi Weighs a Takeover That Could Top $40 Billion
Insmed was one of the very few stocks having a good day in a brutal week for US markets. The biotech's shares closed 20.6% higher at $144.46 on Thursday after reports that French pharmaceutical giant Sanofi is weighing a takeover — a deal that, if it happens, could become the largest biopharma buyout in years. The stock ran as high as $149.07, up 24.4% at its peak, and the move was...
2 Visualizaciones